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        The gastrointestinal tract harbors numerous lu-
minal foreign antigens, including food products 
and commensal and pathogenic microorganisms. 
To maintain appropriate homeostasis in this 
harsh environment, both innate and acquired 
immunity are required (  1  –  3  ). In the intestinal 
epithelium, innate and acquired mucosal im-
munity are bridged in part by intraepithelial T 
lymphocytes (IELs) located between epithelial 
cells (ECs) (  4, 5  ). Previous studies of small intes-
tinal IELs have shown them to possess several 
features that distin  guish them from peripheral T 
cells. For instance, small intestinal IELs are com-
posed of conventional CD4 and CD8         cells, as 
well as unique cells ex  pressing CD8     as a homo-
di  mer (CD8       ) with either TCR        or TCR        
(  4, 5  ). Additionally, in contrast to the strict selec-
tion of CD4 and CD8         T cells in the thymus, 
CD8         IELs possess several unique develop-
mental pathways (  6  –  12  ). 
  Several lines of evidence have demonstrated 
that the composition of IELs in the large intestine 
diff  ers from that in the small intestine (  4, 13  –  15  ), 
but the molecular mechanism underlying this 
distinction has remained obscure. Its identifi  ca-
tion would greatly improve our understanding of 
immune surveillance and homeostasis in the in-
testine, as the physiological function and surround-
ing microenvironment of these two portions of 
the digestive tract are diff  erent. 
  Recently, sphingosine 1-phosphate (S1P) 
has received considerable attention for its bio-
logical activity against diff  erent cell types, in-
cluding lymphocytes (  16, 17  ). To date, fi  ve S1P 
receptors have been identifi  ed, each of which 
associates with a diff  erent type of G protein, re-
sulting in a distinct signal transduction (  16, 17  ). 
Mounting evidence demonstrates that lympho-
cytes preferentially express type 1 S1P receptor 
(S1P  1  ) and S1P  4  , and the former has been shown 
to regulate lymphocyte emigration from the thy-
mus and secondary lymphoid organs (  18, 19  ). 
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  It is well established that intraepithelial T lymphocytes (IELs) are derived from conven-
tional single-positive (SP) thymocytes, as well as unconventional double-negative (DN) 
thymocytes and CD103    CD8         recent thymic emigrants (RTEs). We show that IELs can 
be divided into two groups according to their dependency on sphingosine 1-phosphate 
(S1P) for traffi  cking into the intestines. CD4 or CD8         naive lymphocytes originating 
from SP thymocytes express high levels of type 1 S1P receptor (S1P  1  ), and their preferen-
tial migration into the large intestine is regulated by S1P. In contrast, RTEs migrate 
exclusively into the small intestine, whereas DN thymic IEL precursors expressing either 
TCR         or TCR         migrate into both the small and large intestines. S1P does not play a 
role in the migration pathways of these unconventional thymic IEL precursors. Thus, 
down-regulation of S1P  1   expression or disruption of the S1P gradient halted conventional 
CD4 or CD8         IEL traffi  cking into the intestines, but did not affect the traffi  cking of 
unconventional thymic IEL precursors. These data are the fi  rst to demonstrate that a 
lipid-mediated system discriminates IELs originating from conventional and unconven-
tional thymic precursors. 2336 SPHINGOSINE 1-PHOSPHATE IN IEL TRAFFICKING | Kunisawa et al.
reduction in IEL numbers was observed in the large intestine, 
with a more modest reduction noted in small intestine (  Fig. 
1 A  ).   Based on these fi  ndings, we focused our initial experi-
ment on large intestinal IELs. Flow cytometric analysis re-
vealed that FTY720 treatment almost completely suppressed 
CD4 IELs, which are a major population of large intestinal 
IELs, but increased the number of CD8     cells in the CD3     
T cell fraction (  Fig. 1 B  ). Of the two subsets found in the 
large intestine CD8     IEL fraction, the CD8         IELs were 
dramatically decreased by FTY720 treatment, whereas the 
CD8         IELs showed an increase (  Fig. 1 B  ). Calculation of 
the absolute cell numbers indicated a marked decrease in cell 
numbers of CD4 IELs and CD8         IELs, but a slight increase 
in CD8         IELs after FTY720 treatment (  Fig. 1 C  ). 
  We next used quantitative RT-PCR to test whether the 
sensitivity of large intestinal IELs to FTY720 was attributable 
to the expression of S1P receptors. We found that FTY720-
sensitive CD4 IELs and CD8         IELs expressed high levels of 
S1P  1  , whereas FTY720-insensitive CD8         IELs showed 
barely detectable levels of S1P  1   (  Fig. 1 D  ). Despite their high 
expression of S1P  1  , large intestinal CD4 IELs and CD8         
IELs showed lower, and sometimes barely detectable, levels of 
other types of S1P receptor (S1P  3   and S1P  4  ; unpublished data). 
  We next sought to determine whether FTY720 treat-
ment had to be continuous to block S1P-mediated signals, 
leading to decreased numbers of large intestinal CD4 and 
CD8         IELs. In this experiment, mice were injected with 
FTY720 once daily for several days, and the large intestinal 
IEL population was examined 12 h after each injection. Dra-
matic reductions in CD4 and CD8         IEL numbers were 
observed after a single injection of FTY720, but additional 
injections did not enhance this eff  ect (  Fig. 1 E  ). We next ana-
lyzed the kinetics of IEL recovery after a single FTY720 
treatment. A partial recuperation was detected on day 3, with 
full recovery observed 7 d after the injection (  Fig. 1 F  ). These 
data suggest that the eff  ect of FTY720 on large intestinal 
CD4 IELs and CD8         IELs is rapid, but reversible. 
  As it is well established that intestinal IELs, especially 
CD8         IELs, uniquely express either TCR         or TCR         
(  4, 5  ), we set out to determine whether FTY720 treatment 
infl  uenced the pattern of TCR expression by various subsets 
of large intestinal IELs. We found that CD8         IELs and 
CD4 IELs in the large intestine expressed TCR        , but not 
TCR        , and that both populations of IELs were signifi  cantly 
reduced when mice received FTY720 (  Fig. 1 G  ). In contrast, 
FTY720 binds to four types of S1P receptor, including S1P  1  , 
and induces down-regulation of their expression on thymo-
cytes and lymphocytes (  18, 20, 21  ). Thus, FTY720 induces 
lymphocyte sequestration in lymph and blood by inhibiting 
lymphocyte emigration from the secondary lymphoid organs 
and thymus (  18, 20  –  22  ). In addition, a recent study demon-
strated that oral administration of deoxypyridoxine (DOP), 
which is a vitamin B6 antagonist, increases S1P concentration 
in the thymus and secondary lymphoid organs by inhibiting 
S1P degradation (  23  ). This increased S1P concentration causes 
lymphocytes to accumulate in the thymus and simultaneously 
to be depleted from the blood and lymph (  23  ). We recently 
revealed that S1P also plays an important role in the regula-
tion of peritoneal B cell traffi   cking into intestinal compart-
ments for intestinal secretory IgA production (  24  ). Although 
these fi  ndings suggest that S1P plays an essential role in the 
regulation of lymphocyte traffi   cking in both systemic and 
mucosal immunity, its involvement in IEL traffi   cking remains 
largely unknown. 
  In this study, we aimed to elucidate the role of S1P in the 
traffi   cking of the diff  erent subsets of small and large intestinal 
IELs. We present evidence that the proportion of S1P  1       and 
S1P  1      IELs diff  ers in the small and large intestines. We also 
show that S1P regulates the migration of S1P  1      naive IELs 
into the intestinal compartments through secondary lym-
phoid organs. In addition, we demonstrate that recent thymic 
emigrants (RTEs) preferentially migrate into the small intes-
tine, whereas double-negative (DN) thymocytes expressing 
either TCR         or TCR         migrate into both the small and 
large intestines. Thus, IEL traffi   cking from the thymus into 
the intestines was not regulated by S1P-mediated pathways. 
    RESULTS   
  FTY720 reduces     CD8         and CD4 IELs in the large intestine 
and some populations of CD4 IELs in the small intestine 
  We initially tested whether IEL populations in the small and 
large intestines were aff  ected by treatment with FTY720. 
Confi  rming the fi  ndings of a previous study (  25  ), we showed 
that 5 d of treatment with FTY720 reduced the total cell 
numbers in the spleen without aff  ecting the cell composition 
(Fig. S1 A, available at http://www.jem.org/cgi/content/
full/jem.20062446/DC1). We also observed increased num-
bers of single-positive (SP) thymocytes, whereas CD8    or 
CD4    cells were markedly reduced in the liver of mice re-
ceiving FTY720 (Fig. S1 A) (  22  ). In these mice, a signifi  cant 
Figure 1.  FTY720 treatment dramatically reduces CD4 IEL and CD8 IEL numbers in the large intestine, and modestly reduces CD4 IELs in 
the small intestine. (A) BALB/c mice received 1 mg/kg FTY720 (shaded bar) or water (open bar) for 5 d. IELs were collected from large (left) and small 
(right) intestines 12 h after the fi  nal administration of FTY720. The data represent the  mean  the SEM of eight independent experiments. (B) Flow cyto-
metric analysis was performed to determine the cell population in the CD3 fraction of the large intestinal IELs affected by FTY720. The data are repre-
sentative of fi  ve independent experiments. (C) Cell numbers of each population were calculated using the total cell number and fl  ow cytometric data. The 
error bars represent the average  the SEM (n 	 5). (D) Quantitative RT-PCR analysis for S1P1 was performed using RNA isolated from the sorted large 
intestinal IELs and splenocytes. The relative mRNA was expressed as a ratio to GAPDH. (E) BALB/c mice received a daily intraperitoneal injection of FTY720. 
At 12 h after each injection, the large intestinal IELs were analyzed by fl  ow cytometry (square, CD4; triangle, CD8; circle, CD8). The data represent 
the means  the SD (n 	 5). (F) Flow cytometry was used to evaluate the degree of IEL recovery in the large intestine after one administration of FTY720 
(square, CD4; triangle, CD8; circle, CD8). The data represent the means  the SD (n 	 5). (G) TCR versus TCR expression on large intestinal IELs of 
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mice receiving 5 doses of 1 mg/kg FTY720 or water (mock). The data for cells gated on CD8 (left) and CD4 (right). The data are representative of four 
independent experiments. (H) Flow cytometric analysis was performed to identify the cell population in CD3 cells in small intestinal IELs affected by 
FTY720. The data are representative of fi  ve independent experiments.2338 SPHINGOSINE 1-PHOSPHATE IN IEL TRAFFICKING | Kunisawa et al.
were completely vanished from the small intestinal epithe  lium 
after FTY720 treatment (  Fig. 2 A  ). 
  Although the various subsets of small intestinal CD4 IELs 
express variable levels of CD103, consistently high levels of 
CD103 are expressed by both CD8         IELs and CD8         
IELs (  Fig. 2 A  ). Nonetheless, a few CD8         IELs did not ex-
press CD103, but exhibited high levels of CD62L (  Fig. 2 A  ). 
As with CD62L  high  CD103 CD4 IELs (  Fig. 2 A  ), the 
CD62L  high  CD103 CD8         IELs were eff  ectively suppressed 
by FTY720 treatment (  Fig. 2 A  ). Quantitative RT-PCR 
analysis demonstrated that the level of S1P  1   expression in 
CD62L  high   cells was greatly higher than in CD62L  neg   cells 
(  Fig. 2 B  ), suggesting that the expression pattern of CD62L 
and CD103 in the small intestinal IELs correlates with the 
sensitivity to FTY720. Collectively, these fi  ndings show that 
S1P is primarily responsible for regulating the traffi   cking of 
CD62L  high  CD103 IELs expressing either CD4 or CD8         
in the small intestinal epithelium. 
  In the next series of experiments, we sought to character-
ize the association between the expression of these adhesion 
molecules and FTY720 sensitivity in large intestinal IELs. 
FTY720-sensitive large intestinal CD4 IELs and CD8         
IELs expressed the     4    7 integrin and high levels of CD62L, 
with negative or intermediate levels of CD103 (CD103  int/neg  ; 
  Fig. 2 C  ), which is similar to the FTY720-sensitive CD62L  high 
CD103 population in the small intestinal IELs (  Fig. 2 A  ). In 
contrast, the FTY720-insensitive CD8         population ex-
pressed high levels of CD103, but did not express the     4    7 
integrin and CD62L (  Fig. 2 C  ). Confocal microscopic analy-
sis confi  rmed the presence of CD62L  +   CD4 cells in the large 
intestinal epithelium and FTY720 treatment removed them, 
providing convincing evidence of a correlation between 
CD62L  high  CD103  int/neg   cells and the sensitivity of small and 
large intestinal IELs to FTY720 (  Fig. 2 D  ). Because sacral 
LNs (SLNs) act as draining LNs for the large intestine, we 
next set out to examine FTY720-induced alterations in SLN 
cell populations, demonstrating that FTY720 increased the 
number of CD62L  high   cells in the SLN (  Fig. 2 E  ). 
  Lymphocyte migration is regulated not only by integrins, 
but also by chemokines. S1P is thought to be a modulator of 
cellular responses to some chemokines (  17  ), and CC chemo-
kine receptor 9 (CCR9) is believed to be involved in the 
migration of lymphocytes into the intestinal compartment, 
especially the small intestine (  28  ). Thus, we next investigated 
whether distinct CCR9 expression patterns were observed for 
FTY720-sensitive and -insensitive IELs. We found that CD8         
and CD8         IELs in the small and large intestines expressed 
varying levels of CCR9 (Fig. S2, available at http://www.jem
.org/cgi/content/full/jem.20062446/DC1). The CD8         
population in the large intestinal epithelium was reduced 
after FTY70 treatment, regardless of CCR9 expression (Fig. S2). 
Additionally, no change in the ratio of CCR9 and CCR9 
populations in CD8         IELs was observed after FTY720 
treatment (Fig. S2). Hence, the CCR9 expression level does 
not seem to be linked to the S1P-mediated migration of small 
and large intestinal IELs. 
65% of CD8         IELs expressed TCR        , whereas the re-
maining 35% expressed T CR       . The ratio between TCR        
(68%) and TCR        (32%) in the CD8        IELs was not changed 
by FTY720 treatment (  Fig. 1 G  ), although a modest increase 
in the number of CD8         IELs was observed (  Fig. 1 C  ). These 
data suggest that the effi   cacy of FTY720 treatment does not 
depend on TCR expression. 
  As FTY720 induced a reduction in small intestinal IEL 
numbers, albeit a more modest one than in the large intestine 
(  Fig. 1 A  ), we next focused on the small intestinal IELs. Flow 
cytometric analysis indicated that CD4 IELs were signifi  cantly 
decreased by FTY720 treatment (mock, 13.7  0.89% vs. 
FTY720, 5.7  1.21%; P = 0.006), whereas CD4CD8 double-
positive (DP) IEL numbers were unaltered and CD8    -positive 
cells were increased in CD3  +   fractions (  Fig. 1 H  ). We found a 
modest enhancement of CD8         IELs, but only a slight increase 
in CD8         IELs (  Fig. 1 H  ). Although FTY720 was ob  served to 
aff  ect intestinal IELs, it had no infl  uence over Peyer  ’  s patches 
(PPs) in the small intestine or colonic patches (CPs) and small 
lymphoid aggregates in the large intestine (Fig. S1, A and B). 
We also confi  rmed that the epithelium was specifi  cally re-
moved during the separation process of IELs (Fig. S1 C), and 
found that similar results were obtained when saline perfu-
sion was performed before tissue isolation (unpublished data). 
These fi  ndings suggest that the reduction of CD4 and CD8        
lymphocytes occurred specifi  cally in the IEL population, and 
was not caused by contamination from other tissues. 
  The specifi  c expression pattern of adhesion molecules 
correlates with the sensitivity of small and large intestinal 
IELs to FTY720 
  Tissue-specific lymphocyte trafficking is regulated by a 
combination of adhesion molecules and chemokines. In the 
current study, we focused on two representative adhesion 
molecules expressed specifi   cally on gut-associated lympho-
cytes:     4    7 integrin and CD103 (    E integrin) (  26, 27  ). Each 
population of small and large intestinal CD4 IELs has its own 
distinct expression pattern (  Fig. 2  ).   All CD4 IELs express 
    4    7 integrin, but     80% of CD4 IELs in the small intestine 
are CD103    (  Fig. 2 A  ). After FTY720 treatment, the small 
intestinal epithelia of mice showed a simultaneous decrease in 
the percentage of CD103 CD4 IELs and an increase in the 
percentage of CD103     cells (  Fig. 2 A  ). Because CD4 IELs 
include CD4 SP cells and CD4CD8 DP cells (  Fig. 1 H  ), we 
determined that the CD103   CD4     population contained a 
larger number of CD4 SP cells than DP cells, whereas DP cells 
comprised the majority of the CD103     CD4 cell population 
(  Fig. 2 A  ). FTY720 treatment preferentially reduced CD4 SP 
cells, but had little eff  ect on DP cells, suggesting that CD103 
CD4 SP cells were the main target cell of FTY720 in the small 
intestine (  Fig. 2 A  ). We further divided small intestinal CD4 
IELs according to their expression of CD62L, fi  nding that 
CD103     CD4 IELs do not express CD62L, whereas CD103 
CD4 IELs comprise three populations expressing diff  erent levels 
of CD62L (CD62L  high  , CD62L  int  , and CD62L  neg  ;   Fig. 2 A  ). 
Of  these three populations, only CD62L  high  CD103 CD4 IELs JEM VOL. 204, October 1, 2007 
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                  Figure 2.     Unique expression of adhesion molecules determines the sensitivity of small and large intestinal IELs to FTY720. (A) Small intes-
tines of BALB/c mice that were treated with FTY720 or water (mock) isolated for fl  ow cytometric analysis of the adhesion molecule expression patterns. 
Flow cytometric profi  les of cells gated on CD4 (left), CD103CD4     (left),  CD103  CD4    (left), and CD8     (right) were shown. The data are representative 
of fi  ve independent experiments. (B) Quantitative RT-PCR analysis for S1P  1   on RNA isolated from sorted small intestinal CD4 IELs expressing CD62L  high   or 
CD62L. The relative mRNA is expressed as a ratio to GAPDH. (C) Experiments similar to those shown in A were performed using large intestinal IELs. 
Similar results were obtained from fi  ve independent experiments. (D) Confocal microscopic analysis of the large intestine was performed using antibodies 
for CD4 (green) and CD62L (red), and DAPI (blue) for counterstaining. Bars, 20   
  m. (E) Lymphocytes were isolated from SLN after fi  ve doses of FTY720 as 
shown in A and C, and were examined for the indicated populations by fl  ow cytometry. Experiments were repeated three times.         2340 SPHINGOSINE 1-PHOSPHATE IN IEL TRAFFICKING | Kunisawa et al.
  Naive IELs are the main targets of FTY720 
in the intestinal epithelium 
  The high levels of CD62L expression by FTY720-sensitive 
cell populations (  Fig. 2  ) led us to hypothesize that FTY720 
infl  uences naive IELs. To test this, we examined CD44, CD69, 
and CD62L expression patterns to determine their qualifi  ca-
tion for naive and activated cells (  Fig. 3  ).   We found that large 
intestinal epithelia contained greater numbers of naive cells 
expressing CD62L  high  CD44  int   than did small intestinal epithelia; 
however, despite this diff  erence, naive IELs in both the small 
and large intestines were almost completely suppressed af-
ter FTY720 treatment (  Fig. 3 A  ). In contrast, mice receiving 
FTY720 showed comparable numbers of CD62L  neg  CD69    -
activated IELs in the small intestine and an increased per-
centage in the large intestine (  Fig. 3 B  ). Although FTY720 
signifi  cantly aff  ected naive IELs, it had almost no infl  uence on 
naive cells in the PPs (Fig. S3, available at http://www.jem
.org/cgi/content/full/jem.20062446/DC1A). These fi  ndings 
suggest that the traffi   cking of naive IELs is solely regulated by 
S1P in the small and large intestines, and that the diff  ering 
sensitivities of the small and large intestines to FTY720 can be 
attributed to diff  erences in the composition of these naive cells. 
  FTY720 affects IEL migration and retention, 
but not cell activation 
  To determine whether FTY720 reduced naive IELs by in-
hibiting cell migration into the intestine, we intravenously 
transferred CFSE-labeled T cells isolated from mesenteric LNs 
(MLNs) and SLNs into mice and examined their migration 
into the intestinal compartments. As previously documented 
(  18, 20  –  22  ), the number of CFSE     T cells decreased in the 
blood of mice treated with FTY720 both 1 and 7 d after 
the transfer (  Fig. 4 A  ). In these mice, migration of CFSE  +   
cells into the MLN and SLN was reduced by FTY720 treat-
ment, whereas that into the PPs was increased (  Fig. 4, B  –  D  ), 
which was consistent with a previous study (  29  ). Flow cyto-
metric analysis of CFSE     cells in these tissues revealed that 
their naive cell phenotype persisted after FTY720 treatment 
(  Fig. 4, B  –  D  ). We also found CFSE     cells in the large intes-
tinal epithelium 1 d after the transfer, but the numbers of 
these cells were signifi  cantly decreased in mice treated with 
FTY720 (  Fig. 4 E  ). Consistent with a previous work (  30  ), 
fewer cells migrated into the small intestine than the large 
intestine under these experimental conditions (  <  0.01% cells 
were CFSE     1 d after the transfer; unpublished data). However, 
similar results were obtained in both the small and large intes-
tines 7 d after transfer, demonstrating that the migration of 
CFSE     cells was signifi  cantly curtailed by FTY720 in both 
the small and large intestines (  Fig. 4 E  ). We obtained similar 
results when T cells isolated from GFP-transgenic mice were 
used instead of the CFSE-labeled system, ruling out the pos-
sibility that the CFSE     cell numbers in FTY720-treated mice 
were reduced because of cell division during these 7 d (un-
published data). These fi  ndings suggest that prevention of 
ongoing naive cell homing into the gut from the systemic 
immune compartments is one mechanism of FTY720-induced 
naive IEL reduction. 
  As shown in   Fig. 1 H  , FTY720-mediated reduction of 
naive IELs was rapid (within 12 h). If this is attributable only to 
the inhibition of naive cell entry into the intestine, the turnover 
rate in the intestinal epithelium should be 12 h. To ex-
amine this, we performed a BrdU time course study of IELs. 
Figure 3.  FTY720 selectively suppresses naive-type IELs in both the small and large intestines. IELs were isolated from the small and large intes-
tines of mice receiving FTY720, as shown in Fig. 1. Flow cytometry was used to analyze the effects of FTY720 on naive (CD62LhighCD44int; A) and activated 
(CD62LnegCD69; B) IELs in the CD3 population. The data are representative of four independent experiments.JEM VOL. 204, October 1, 2007 
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Figure 4.  FTY720 inhibits T cell migration to the intestine and retention in the intestinal epithelium without affecting cell activation. (A–E) On 
day 1 (blood and large intestine) or day 7 (all tissues) after the adoptive transfer of CFSE-labeled T cells, cells were isolated from the blood (A), MLN (B), SLN 
(C), PP (D), and intestinal epithelium (E) of mice treated with water (mock, open) or FTY720 (fi  lled), and the total number of CFSE cells was examined. The 
data are representative of four independent experiments, and graph data represent means  SEM (n 	 4). (F) Cell numbers of BrdU naive (CD62Lhigh) CD4 IELs 
measured in large (left) and small (center) intestinal epithelia and MLN (right) of mice from day 6 to 12 after a single BrdU injection. The data represent the 
means  the SEM (n 	 5). (G) Cell numbers of naive (CD62Lhigh and CD44int) and activated (CD62L and CD69) cells in CFSE populations were measured in the 
small and large intestinal epithelia of mice receiving mock (open circle) or FTY720 (fi  lled circle) treatment (right) 24 h after transfer.2342 SPHINGOSINE 1-PHOSPHATE IN IEL TRAFFICKING | Kunisawa et al.
rates of naive CD4 IELs were 3 d in both small and large 
intestines (  Fig. 4 F  ). In contrast, the cell number of BrdU  +   
cells in the MLN was maintained at a similar level during the 
experiment, excluding the possibility that the decay curves 
refl  ected the survival time of BrdU     cells. These fi  ndings led 
us to suggest that FTY720 aff  ects naive IEL retention in the 
intestinal epithelium, which would lead to a reduction in the 
number of CFSE IELs. To test this hypothesis, we examined 
CFSE cells in the intestines 1 d after the transfer because 
few cells migrated into the intestinal epithelium after this time 
under this experimental condition (  Fig. 4 E  ). We observed a 
signifi  cant decrease in naive (CD62L  high  CD44  int  ), but not in 
activated (CD62L  neg  CD69    ), CFSE-negative cells residing in 
the small and large intestines of FTY720-treated mice (  Fig. 4 G  ). 
To examine the possibility that FTY720 treat  ment could 
lead to the disappearance of resident naive IELs by triggering 
either the activation of naive IELs or their programmed cell 
death, we next cultured naive lymphocytes with FTY720 for 
2 d and examined their phenotype and viability and noted no 
changes in either cell activation or viability (Fig. S3 B and 
not depicted). These fi  ndings suggest that FTY720 inhibits 
not only naive lymphocyte migration into the intestine from 
the systemic immune compartments but also their retention 
in the intestinal epithelium. 
  Inhibiting S1P lyase activity disrupts the S1P gradient 
and hampers cell traffi  cking into the intestine 
  To further confi  rm the involvement of S1P in the regulation 
of IEL traffi   cking, we next used DOP, which was reported to 
disrupt the S1P gradient by inhibiting S1P lyase (  23  ).   Our 
results confi  rmed this, and demonstrated that disruption of 
the S1P gradient by oral feeding with DOP for 3 d resulted 
in the accumulation of SP thymocytes (  Fig. 5 A  ). DOP treat-
ment also reduced the number of naive IELs in both the small 
and large intestines (  Fig. 5 A  ). An adoptive-transfer experi-
ment using CFSE-labeled naive T cells revealed that DOP 
treatment inhibited their traffi   cking into the intestines (  Fig. 
5 B  ). These fi  ndings convincingly demonstrated that an S1P-
mediated pathway regulates the naive IEL traffi   cking. 
  FTY720-insensitive traffi  cking of unconventional thymic IEL 
precursors into the intestinal epithelium 
  Our focus was next shifted to FTY720-insensitive IEL popu-
lations, such as CD8         IELs. Recent studies have revealed 
several distinctive developmental pathways for IELs, includ-
ing unconventional thymic IEL precursors (  6  –  11  ). Thus, 
we examined whether S1P mediated the migration of these 
thymus-originated IEL precursors into the small and large 
intestines using the intrathymic FITC-labeling system. By 24 h 
By 6 d after the single BrdU injection, BrdU-labeled cells 
were barely detected in the thymus (unpublished data), indi-
cating that newly developed naive T cells were BrdU nega-
tive. The number of BrdU     naive CD4 IELs started to fall 
on day 8 in the large intestine and day 6 in the small intestine, 
after a linear regression (  Fig. 4 F  ). The estimated 50% turnover 
Figure 5.  Disruption of S1P gradient halts naive IEL migration. 
(A) Lymphocytes were collected from the thymus (top) and large (middle) 
and small (bottom) intestines of mice treated with DOP (right) or water (left) 
for 3 d, and were analyzed for naive cells in the CD3 population. The data 
are representative of three independent experiments. (B) At 7 d after the 
adoptive transfer of CFSE-labeled T cells, cells were isolated from the large 
(left) or small (right) intestinal epithelia of mice treated with mock (open circle) 
or DOP (fi  lled circle), and the total number of CFSE cells was examined.
Figure 6.  FTY720-insensitive migration of RTEs and thymic DN IEL precursors expressing TCR or TCR into the intestinal epithelium. 
By 24 h after intrathymic FITC injection, the cell populations in FITC and FITC thymocytes (A) in mock-treated (left) or FTY720-treated (right) mice were 
examined by fl  ow cytometry. Cells were isolated from the blood (B), MLN (C), large intestine (D), and small intestine (E) and examined by fl  ow cytometry. 
Absolute cell numbers of FITC cells were calculated using the total cell numbers and fl  ow cytometric data. Expression of CD4, CD8, CD8, CD11b, CD11c, 
CD103, c-kit, IL-7R, TCR, and TCR was examined in FITC cells. The graph data depicts the means  the SEM (n 	 4). Other data are representative of 
at least four independent experiments. 
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after the intrathymic FITC injection, we found that each 
population of thymocytes was equally stained with FITC. 
Thus, comparable percentages of CD4 and CD8 SP, DP, and 
DN thymocytes were found in FITC     and FITC thymo-
cytes in mock-treated control mice (  Fig. 6 A  ). Additionally, 
FTY720 treatment resulted in similar accumulation levels of 
CD4 and CD8 SP thymocytes in both FITC     and FITC    –    
fractions, suggesting that FTY720 inhibited the emigration of 
SP thymocytes regardless of FITC labeling (  Fig. 6 A  ). These 
eff  ects coincided with the barely detectable levels of CD4 
and CD8 SP FITC     cells in the blood circulation of FTY720-
treated mice (  Fig. 6 B  ). 
  Consistent with previous results (  8  ), FITC     cells were 
detected in the secondary lymphoid organs (such as the MLN) 
in mock-treated control mice (  Fig. 6 C  ). The positive fraction 
mainly consisted of cells expressing CD4 or CD8        , but not 
DN or DP cells (  Fig. 6 C  ). The group of mice treated with 
FTY720 possessed barely detectable levels of FITC     cells 
(  Fig. 6 C  ), which was plausibly caused by the inhibition of SP 
thymocyte emigration by FTY720. These fi  ndings led us to 
conclude that the pathway from the thymus into the MLN is 
regulated by S1P. 
  FITC     cells were found in the large intestine of mock-
treated control mice (  Fig. 6 D  ). In FTY720-treated mice, a 
similar percentage of FITC     cells was observed, but the ab-
solute FITC     cell number was decreased because of the re-
duction in total cell numbers in large intestinal IELs (  Figs. 1 A 
and 6 D  ). Flow cytometric analysis revealed that FITC     cells 
were comprised of DN cells in addition to cells expressing 
either CD8     or CD4, and that they did not contain any DP 
cells (  Fig. 6 D  ).   As with FITC     CD4 and CD8     cells in the 
MLN (  Fig. 6 C  ), FTY720 treatment inhibited the traffi   cking of 
FITC     cells expressing CD4 or CD8     into the large intestine, 
but did not infl  uence the migration of DN cells (  Fig. 6 D  ). 
As recent studies have revealed unconventional CD8         IEL 
precursors in the DN thymocytes (  6, 7, 12  ), we analyzed TCR 
expression to reveal that FITC     DN cells expressed TCR         
(10  –  20%) or TCR         (10  –  20%;   Fig. 6 D  ). We also found that 
FITC     DN cells barely expressed c-kit, but 50  –  60% of 
FITC     DN cells expressed CD11b and/or CD11c, suggesting 
that they were phagocytic cells taking up leaked FITC or 
FITC-labeled apoptotic cells (  Fig. 6 D  ). In addition, FITC     
TCR     DN cells were not detected when the same amount 
of FITC was injected intravenously (unpublished data), ex-
cluding a possibility that the FITC  +   TCR     DN cells ob-
served in this experiment were labeled in the extrathymic 
compartments. These fi  ndings indicate that some FITC     DN 
cells are derived from phagocytic cells, whereas others are 
composed exclusively of cells expressing TCR        or TCR       . 
In agreement with these fi  ndings, considerable numbers of 
DN cells expressing TCR         or TCR         were detected in 
the blood of FTY720-treated mice, although FTY720 signif-
icantly reduced CD4 and CD8 SP cells in the blood (Fig. 
S3 C). These data suggest that thymic CD4 and CD8 SP cells 
migrate into the large intestine via an S1P-mediated pathway, 
and DN cells expressing TCR         or TCR         migrate via 
FTY720-insensitive manner. 
  As one might expect based on the data summarized in 
  Fig. 1  , the number of FITC     cells in the small intestine re-
mained similar after FTY720 treatment (  Fig. 6 E  ), and the 
FITC  +   cells in the small intestine of mock-treated control 
mice were comprised of DP and DN cells, as well as cells ex-
pressing either CD4 or CD8     (  Fig. 6 E  ). Because CD4     cells 
exclusively expressed TCR         and no cells expressed CD4 
together with CD8     in the FITC     fraction, it seems that DP 
IELs are TCR          +  CD8             CD4 cells uniquely observed in 
the intestinal epithelium, and are not thymic DP cells (  Fig. 6 E  ). 
Small intestinal FITC     DN IELs included cells expressing 
CD11b and/or CD11c (   30%), TCR        (20 –  30%), or TCR         
(30  –  40%) and few cells expressing c-kit or IL-7R (  Fig. 6 E  ). 
Like the large intestine, FITC     TCR     DN cells were not 
detected when the same amount of FITC was injected intra-
venously (unpublished data). These fi  ndings suggest that, 
similar to the large intestine, some small intestinal FITC     
DN cells are derived from phagocytic cells, whereas others 
are composed exclusively of cells expressing TCR         or 
TCR        , and not cells derived from TCR-negative DN (triple-
negative [TN]) cells.   
  Intriguingly, the ratio of CD8     to CD4 cells was higher in 
the small intestine than in MLN or the large intestine (  Fig. 6, 
C and D ). Those CD8    FITC     IELs were composed of CD8        
IELs (75%) and CD8         IELs (25%;   Fig. 6 E  ), the latter of which 
expressed CD103, which is a recently reported identifying char-
acteristic of RTEs (  Fig. 6 E  ) (  8, 31  ). FTY720 signifi  cantly in-
hibited the migration of CD4 cells into the small intestine (mock, 
4.3      0.35%; FTY720, 1.1  0.23%; P = 0.009), whereas 
other populations including TCR         DN cells, TCR         DN 
cells, and CD103     CD8         RTEs were un  aff  ected (  Fig. 6 E  ). 
Figure 7.  Dependency of lymphocyte migration into the small 
and large intestines on S1P. Conventional CD4 (green) and CD8 
(orange) SP thymocytes emigrate from the thymus into secondary lym-
phoid organs, and, subsequently, into the small and large intestines. 
These SP cells express high levels of S1P1 and pathways regulated by 
S1P (blue lines), and can be inhibited by FTY720. Unconventional thy-
mic IEL precursors, including mature post-selected TCR DN cells 
(red) derived from TP (CD4CD8CD8) thymocytes (pink), TCR 
DN thymocytes (purple), and CD103 CD8 RTEs (yellow), migrate 
into the intestinal epithelium through FTY720-insensitive pathways 
(red lines).JEM VOL. 204, October 1, 2007 
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CD8         under the infl  uence of IL-15 (  6  ). It has been shown 
that TN thymocytes emigrate from the thymus into the in-
testinal epithelium, where they characteristically express c-kit 
and IL-7R on the cell surface and mRNA encoding CD3  
   (  7  ). 
This study demonstrates that FITC     thymic IEL precur-
sors in the intestine of FTY720-treated mice express either 
TCR         or TCR        , but not c-kit and IL-7R (  Fig. 6, D and E  ). 
Thus, although it remains to be determined whether other 
CD8         IEL-generating pathways (such as the cryptopatch-
dependent route) are dependent on S1P (  11  ) and whether 
FTY720-resistant S1P-mediated pathways (e.g., S1P  2  -mediated 
pathway) are involved in the traffi   cking of DN thymocytes 
into the intestines (  21  ), our fi  ndings suggest that mature post-
selected TCR             DN thymocytes and TCR             DN thy-
mocytes, but not TN thymocytes, migrate into the gut in a 
FTY720-insensitive manner. 
  In addition to thymic DN IEL precursors, the migration 
of RTEs from the thymus into the small intestine was not 
inhibited by FTY720 treatment (  Fig. 6 E  ). It has been shown 
that RTEs uniquely express     4    7 integrin and CCR9 in the 
thymus, which enables them to migrate directly into the 
small intestinal epithelium without undergoing activation in 
the secondary lymphoid organs (  8  ). Their preferential migra-
tion into the small intestine rather than the large intestine 
can be explained by their CCR9 expression in the thymus, as 
small intestinal ECs, unlike those of the large intestine, pro-
duce an abundance of the CCR9 ligand CCL25 (  28  ). Our 
current data indicate that FTY720 does not aff  ect the direct 
migration of RTEs from the thymus into the small intestine. 
Although FTY720 had no eff  ect on RTEs, which were 
known to express CD62L (  8  ), naive CD62L  high   cells were 
barely detected in the small intestine of FTY720-treated mice 
(0.1%;   Fig. 3 A  ). This discrepancy is caused by the fact that 
the RTEs are very minor population in the small intestinal 
IELs. In this issue, it was previously demonstrated that     2% 
of cells were RTEs in CD62L  high  CD44  int   CD8         cells, 
which consisted of 5% small intestinal CD8         IELs (  8  ). 
Therefore, an estimated percentage of RTEs in the total small 
intestinal IELs, including CD4, CD8        , CD8        , and DN 
cells, is 0.1%. Thus, it is likely that the RTEs are present, 
but diffi   cult to detect, in the small intestine of FTY720-
treated mice. Additionally, there is still a minor possibility of 
the involvement of other cells that express CD103, CD62L, 
and CCR9 (e.g., circulating naive CD8 T cells and SP CD8 
thymocytes). However, together with well-established ef-
fects of FTY720 on circulating naive CD8 T cells and SP 
CD8 thymocytes on their retention in the secondary lym-
phoid organs and thymus (  16, 17  ) and our data on FITC-
labeling experiments, the most plausible interpretation is that 
RTEs use the unique FTY720-insensitive traffi   cking path-
way from the thymus into the small intestinal epithelium. 
  In addition to activated platelets, mast cells, and mono-
cytes, dietary sphingolipids are another source of S1P (  36  ). 
Interestingly, enzymes involved in the generation of sphin-
gosine, which is a precursor of S1P, are principally expressed 
in the intestinal tracts, where their expression patterns diff  er 
  Collectively, our current fi  ndings demonstrate that thy-
mic DN IEL precursors expressing TCR         or TCR         are 
likely to migrate into the large or small intestine, whereas 
RTEs preferentially migrate into the small intestine (  Fig. 7  ). 
Unlike S1P-dependent SP thymocytes  ’   migration into the 
intestine through secondary lymphoid organs, the migration 
pathway of unconventional IEL precursors is totally insensi-
tive to FTY720 treatment (  Fig. 7  ). 
    DISCUSSION   
  In this study, we demonstrate that the lipid mediator S1P 
determines whether a given type of IEL goes into the small 
or the large intestine, resulting in varying proportions of naive 
cells, RTEs, and thymic DN IEL precursors in the two com-
partments. Naive IELs, which primarily express S1P  1  , are 
more abundant in the large intestine than in the small intes-
tine (  Fig. 3 A  ), explaining why large intestinal IELs are more 
sensitive to FTY720 or DOP (  Figs. 1, 3, and 5  ). These fi  nd-
ings confi  rm previous reports that identify CD62L     cells as 
the primary targets of FTY720 in systemic immunity, and 
show that S1P  1   is preferentially expressed on naive and cen-
tral memory T cells rather than activated T cells for effi   cient 
S1P-mediated migration (  18, 32, 33  ). In contrast, activated 
IELs, which were abundant in the small intestine but barely 
detectable in the large intestine, did not respond to FTY720 
(  Figs. 3 and 4  ). In this context, a previous study demonstrated 
that the activation marker CD69 itself induced down-regulation 
of S1P  1  , thereby rendering activated cells unresponsive to 
S1P (  34  ). These fi  ndings off  er a plausible explanation for why 
activated IELs expressing CD69 in the intestinal compart-
ments are less reactive to FTY720 (  Fig. 3 B  ). 
  Our results imply that FTY720 inhibits not only the traf-
fi  cking of naive IELs into the intestine, but also their retention 
in the intestinal epithelium (  Fig. 4   and Fig. S3). This might 
explain why naive T cells accumulated in the SLN of  FTY720-
treated mice, despite their reduced migration from the blood 
into the SLN (  Figs. 2 E and 4 C  ). A previous work has dem-
onstrated that lymphocyte exit from the skin is not a random 
process, but is regulated by a chemokine-mediated pathway (  35  ). 
Additionally, we recently reported that S1P regulates B cell 
retention in the peritoneal cavity (  24  ). Our current study there-
fore not only confi  rms that lymphocyte traffi   cking in nonlym-
phoid tissues is regulated biologically, but also shows that S1P 
plays an important role in that pathway.   
  In contrast to the S1P-dependent traffi   cking of naive cells 
into the intestines through secondary lymphoid organs, thy-
mic DN IEL precursors migrate into both the small and large 
intestines in an FTY720-insensitive manner ( Fig. 6 ). Recently, 
several lines of evidence have proposed the presence of 
IEL precursors in DN thymocytes, including TCR             
DN thymocytes, TCR          +   DN thymocytes, and TCR            –    
CD25  +   TN thymocytes (  6, 7, 12  ). TCR          +   DN thymocytes 
are known as mature post-selected DN thymocytes, as they 
arise from CD8          +   CD4     CD8             triple-positive (TP) 
thymocytes after agonist selection (  6  ). TCR          +   DN thymo-
cytes then migrate into the intestine, where they reinduce 2346 SPHINGOSINE 1-PHOSPHATE IN IEL TRAFFICKING | Kunisawa et al.
was performed to purify the lymphocytes. IELs were collected from the layer 
between the 40% and 75% fractions. The spleen, thymus, MLN, SLN, PPs, 
and CPs were removed, and single-cell suspensions were prepared by passing 
them through a 70-  
  m mesh fi  lter, as previously described (  24, 44  ). Lym-
phocytes were prepared from the liver according to a previously established 
method (  45  ). In brief, the liver was passed through a 200-gauge stainless 
mesh to obtain single cells. These cells were treated with erythrocyte-lysing 
solution (155 mM NH  4  Cl, 10 mM KHCO  3  , 1 mM EDTA, and 170 mM 
Tris-HCl, pH 7.3) to remove the erythrocytes, and were then fractionated 
by centrifugation in 35% Percoll. 
    Flow cytometry and cell sorting.     Flow cytometry and cell sorting were 
performed as previously described (  24, 44  ). Cells were preincubated with 
anti-CD16/32 antibody, and then stained with fl  uorescent antibodies spe-
cifi  c for CD4, CD8    , CD8    , CD11b, CD11c, CD44, CD62L, CD69, 
CD103, c-kit, IL-7R, TCR    , TCR        ,     4    7 integrin (BD PharMingen), 
and CCR9 (R  &  D Systems). A Viaprobe (BD PharMingen) was used to dis-
criminate between dead and living cells. Flow-cytometric analysis and cell 
sorting were performed using FACSCalibur and FACSAria (BD Bios-
ciences), respectively. 
  Histological analysis.     Immunohistochemical analysis was performed as 
previously described (  40  ). In brief, large intestines were fi  xed in 4% parafor-
maldehyde (Wako) and treated with a sucrose gradient after extensive washing. 
The tissue was embedded in Tissue-Tek OCT compound (Sakura Fine-
technical). For confocal microscopy analysis, TSA-direct kit (Perkin Elmer) 
was used according to the manufacturer  ’  s instructions. In brief, 6-  
  m 
cryostat sections were treated with 3% H  2  O  2   in PBS for 15 min to quench 
endogenous peroxidase activity. Sections were preblocked with anti-CD16/
CD32 antibody in PBS containing 2% FCS for 15 min at room temperature, 
and stained with biotin-conjugated antibodies specifi  c for CD4 or CD62L 
for 15 h at 4  °  C. After washing with TNT buff  er (0.1 M Tris-HCl, pH 7.5, 
0.15 M NaCl, and 0.05% Tween20), sections were treated with horseradish 
peroxidase  –  conjugated streptavidin in TNT buff  er for 30 min at room 
temperature. After washing with TNT buff  er, amplifi  cation of the fl  uorescent 
signal with FITC or Cy5-tyramide was performed. The specimens were an-
alyzed using a confocal laser-scanning microscope (TCS SP2; Leica). Hema-
toxylin and eosin staining was used to confi  rm the dissociation of the epithelial 
region, as previously described (  40  ) 
  Quantitative RT-PCR.     To measure mRNA expression for S1P receptors, 
quantitative RT-PCR using LightCycler (Roche) was performed as previously 
described ( 24  ). Total RNA was prepared using TRIzol reagent (Invitrogen), and 
cDNA was synthesized using Powerscript reverse transcriptase (BD Biosciences). 
The oligonucleotide primers and probes specifi  c for S1P  1   (forward primer, 
TACACTCTGACCAACAAGGA; reverse primer, ATAATGGTCTCT-
GGGTTGTC; FITC-probe, TGCTGGCAATTCAAGAGGCCCATCATC; 
and LCRed 640-probe, CAGGCATGGAATTTAGCCGCAGCAAATC) 
and GAPDH (forward primer, TGAACGGGAAGCTCACTGG; reverse 
primer, TCCACCACCCTGTTGCTGTA; FITC-probe, CTGAGGAC-
CAGGTTGTCTCCTGCGA; and LCRed 640-probe, TTCAACAGCA-
ACTCCCACTCTTCCACC) were designed and produced by Nihon Gene 
Research Laboratory. 
  Adoptive transfer of CFSE-labeled lymphocytes.     CD3     T cells were 
isolated from the MLN and SLN using anti  –  mouse CD3-coupled micro-
beads and a MACS column (Miltenyi Biotec) as previously described (  44  ). 
For CFSE labeling, 10  7   cells were incubated in the dark with 10   
  M CFSE 
(Invitrogen) for 10 min at 37  °  C, before being washed twice with PBS 
(  8, 24  ). Labeled cells (2      10  7  ) were adoptively transferred via the tail vein 
into naive mice, which were either treated with FTY720 5 min after the cell 
transfer or left untreated. Lymphocytes were isolated from the MLN, SLN, 
blood, PPs, and small and large intestinal epithelium 24 h and 7 d after the 
transfer for fl  ow-cytometric analysis. 
according to the intestinal compartment (  37, 38  ). For in-
stance, alkaline sphingomyelinase and neutral ceramidase, 
which are both important enzymes in the sequential degrada-
tion of sphingomyelin and ceramide to generate sphingosine, 
were predominantly expressed at the luminal side of the brush 
border in the distal jejunum and ileum, indicating that the 
amount of sphingosine was much lower in the upper and 
middle sections than in the lower sections of the small and 
large intestines (  37, 38  ). The varying expression patterns of 
these enzymes, which might determine to what degree IELs 
migrate into a given region of the small or large intestine, 
depend on S1P under natural conditions. Although FTY720 
inhibits the naive cell traffi   cking into the intestinal epithe-
lium by preventing their emigration from the secondary lym-
phoid organs in our experimental condition (  Fig. 2 E  ), it is 
interesting to examine whether luminal sphingosine-derived 
S1P regulates intestinal immunity, including T cell traffi   cking. 
Studies are currently underway in our group to further inves-
tigate this issue. 
  As S1P mediates the migration of mucosal T cells, such as 
IELs, it might also regulate other groups of immunocompe-
tent and/or pathological cells in the mucosal immune system. 
Most irritations of the gastrointestinal tract, including infl  am-
matory bowel diseases (IBDs) and food allergies, are caused 
by the infl  ux of pathological cells into the intestine from 
systemic compartments (  39, 40  ). If the migration of these 
pathological cells to the gastrointestinal tract is indeed S1P-
dependent, it should be susceptible to FTY720, perhaps 
opening a new avenue for the treatment of IBDs and intesti-
nal allergic diseases. Indeed, our previous study demonstrated 
that FTY720 eff  ectively inhibited the development of IBDs 
in IL-10  –  defi  cient mice (  41  ). Moreover, our recent separate 
studies show that FTY720 is also eff  ective at preventing the 
development of allergic diarrhea by inhibiting pathogenic 
cell migration into the large intestine (  42  ). In addition to reg-
ulating IEL traffi   cking under natural conditions, these fi  nd-
ings suggest that the S1P-mediated pathway is involved in the 
development of immunological diseases of the intestine, such 
as IBDs and food allergies. 
    MATERIALS AND METHODS   
  Mice and experimental treatment.       Normal female BALB/c mice (7  –  9 wk 
of age) were purchased from Japan Clea or Japan SLC. All mice were 
provided with sterile food and water ad libitum. Mice were injected intra-
peritoneally with 1 mg/kg FTY720 (Novartis Pharma) to assess reactivity 
(  18, 24  ). To inhibit S1P lyase activity, the mice received drinking water 
containing 10 g/liter glucose and 30 mg/liter 4-deoxypyridoxine-HCl 
(Sigma-Aldrich) for 3 d (  23  ). All animals were maintained in the experimen-
tal animal facility at the University of Tokyo, and the experiments were 
conducted in accordance with the guidelines provided by the Animal Care 
and Use Committee of the University of Tokyo. 
    Lymphocyte isolation.       Single IEL cells were isolated from the small and 
large intestinal epithelium as previously described (  43  ). In brief, after remov-
ing the PPs, the small and large intestines were dissected into short segments 
and stirred at 37  °  C in prewarmed RPMI 1640 containing 2% FCS and 
0.5 mM EDTA for 15 min, followed by vigorous shaking for 15 s. This process 
was repeated twice. A discontinuous Percoll density gradient centrifugation JEM VOL. 204, October 1, 2007 
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  Intrathymic labeling of thymocytes with FITC.     The intrathymic in-
jection of FITC was performed as previously described (  8, 22, 31  ). In brief, 
10   
  l FITC solution (1 mg/ml; Sigma-Aldrich) was injected into the thymus 
of anesthetized mice and the skin was closed with silk sutures. For FTY720 
treatment, the mice were treated with FTY720 5 min before the FITC 
injection. Lymphocytes were isolated from the thymus, blood, MLN, and 
small and large intestinal epithelium 24 h after the FITC injection for fl  ow-
cytometric analysis. 
  BrdU incorporation and measurement.     Mice were injected intraperi-
toneally with 1 mg BrdU (Sigma-Aldrich) in PBS as previously described 
(  46  ). At the indicated times, the IELs were isolated from the small and large 
intestines and stained with fl  uorescent antibodies specifi  c for CD4 and 
CD62L (BD PharMingen). BrdU incorporation was detected by fl  ow cyto-
metry with a BrdU Flow kit according to the manufacturer  ’  s instructions 
(BD Biosciences). 
  Statistics.     Results were compared using the Student  ’  s or Welch  ’  s   t   test. 
Statistical signifi  cance was established at P      0.05. 
  Online supplemental material.     Fig. S1 shows the data on CD4 and CD8 cells 
in the thymus, spleen, liver, PPs, CPs, and lymphocyte aggregates of mice treated 
with FTY720. Fig. S2 provides the data on the CCR9 expression on small and 
large intestinal CD8 IELs. Fig. S3 shows data on FACS profi  le in the PPs of 
FTY720-treated mice, naive T cells cultured with FTY720, and cell numbers of 
blood lymphocytes of FTY720-treated mice. The online version of this article is 
available at http://www.jem.org/cgi/content/full/jem.20062446/DC1. 
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